The AIM of the present study was to explore the level of depression in the respondents using the Zung self-rating depression scale (SDS) and fi nd a correlation with the levels of the thyroid-stimulating hormone (TSH) and the anti-thyroid peroxidase antibodies (anti-TPO), the age and gender of the participants. PATIENTS AND METHODS: 2401 subjects aged 20-84 yrs were included, 1344 of them female aged 48.7 ± 14.4 yrs and 1057 male, aged 46.5 ± 14.5 yrs (p < 0.001). All participants completed the Zung SDS questionnaire and a depressive score was calculated and interpreted as follows: less than 49 points -no depression, between 50 and 59 points -mild depression, between 60 and 69 points -moderate depression and more than 69 points -severe depression. Body height and weight were measured and serum TSH and Anti-TPO were determined. RESULTS: SDS was higher in the females (47.6 ± 9.7 vs. 41.7 ± 8.6, p < 0.001) and correlated with the subjects' age (Spearman's ρ female = 0.447, p < 0.001, ρ male = 0.402, p < 0.001). Depression was more prevalent in the females (all p < 0.001) with hypothyroidism than in the euthyroid subjects (odds ratio 1.8, 95% CI 1.15-2.80, p < 0.011). The odds ratio for depression was 3.47 (2.64-4.57) for the female gender and the risk of depression increased by 6% (5 -7) with each added year of age. The anti-TPO, BMI and waist circumference did not infl uence the regression models. CONCLUSION: The depressive score was higher in the females and increased with age. Hypothyroidism determined a higher risk of depression in the females.
INTRODUCTION
Thyroid dysfunction affects profoundly and diversely the human organism. This disorder has been associated with a spectrum of more or less typical somatic signs and symptoms. A variety of neuropsychiatric phenomena and symptoms that are different for each specifi c type of dysfunction have been described in subjects with hypo-or hyperthyroidism as well. Hypothyroidism may be manifested with impaired concentration and short-term memory, mental slowing, emotional instability. The overt hypothyroidism has been stated as the most common cause of reversible dementia. 1 Though the well recognized combination of bradypsychia-bradylalia is observed in severe and long-standing hypothyroidism, often the severity of the hormonal defi ciency is not convincingly related to the neuropsychiatric manifestations. 2 Depressive symptoms have been reported in about 40% of the subjects with overt hypothyroidism, but the relationship between the two conditions remains elusive. 3 The association of subclinical hypothyroidism (SHT) with depression is also debatable. Guimaraes J et al. found a three-fold increase in the risk for depression in subjects with TSH above 10 IU/l and a 8.7-fold increase in those with overt hypothyroidism. 4 Similarly, Demartini B, et al. reported depressive symptoms in 63.5% of the subjects with SHT in their cohort. 5 Depression was observed in 50% of the SHT patients studied by Chuerie V, et al. 6 The same authors found elevated TSH in 30% of the subjects with depressive disorders. In contrast, Grabe HJ et al. did not fi nd any correlation between the thyroid function and the psychometric indices assessed by them in a large-scale study of the neuropsychiatric and somatic symptoms in a cohort with no previously known thyroid disorder. 7 They found, however, signifi cant differences between the healthy controls and the subjects with elevated antithyroid antibodies irrespective of the thyroid function (euthyroid or hypothyroid). The authors of the large population-based study HUNT 2 in Norway failed to fi nd any similar correlation between depression indices and anxiety on the one hand and thyroid autoimmunity on the other. 8 The psychoemotional status might be assessed by various tools but the published data using the Zung self-rating depression scale (SDS) are scant. 9, 10 The aim of the present study was to fi nd the prevalence and level of depression in the participants of a population-based study and to investigate their association with gender, age, TSH and anti-TPO levels.
PATIENTS AND METHODS
The study was a part of the fi rst population-based study on the prevalence of the most common endocrine disorders in Bulgaria. Two thousand and one adult subjects were recruited in six cities and the surrounding areas (Sofi a, Plovdiv, Kurdjali, Veliko Tarnovo, Trojan, Sandanski). The participants were randomly selected from the population registries of these cities. The sample size and age structure were planned in correspondence with the age structure of the population as determined by the latest census in 2005 (44.5% young, 35.5% middle-aged and 20% elderly). Informed consent was obtained from all participants and the study was approved by the local ethics committee. The studied subjects completed a questionnaire regarding personal medical history, current disorders (thyroid, diabetes, malignancies, cardiovascular), past surgeries, medication, current smoking status and family history.
All participants completed the Zung SDS and the resulting scores were summed and recalculated to 100%. The SDS index (SDSi) was interpreted as follows: up to 49 -no depression; 50-59 -mild depression; 60-69 -moderate depression; 70+ -severe depression. Additionally two categories were defi ned -without criteria for depression (SDSi ≤ 49) and with criteria for depression (SDSi > 49) irrespective of the severity of depression.
Body mass, height and waist circumference were measured and body mass index was calculated by the standard formula. Morning fasting blood samples were collected to determine TSH and Anti-TPO antibodies. Ultrasensitive TSH was determined by a microparticle immunoenzymatic assay (MEIA) using an automated analyzer AxSYM (ABBOTT, USA). The analytic sensitivity of the method was 0.01 IU/l. TSH reference range was 0.39-4.20 IU/l. We divided the subjects by the measured TSH level into three categories -low TSH (< 0.39 IU/l), normal TSH and elevated TSH (> 4.2 IU/l). The anti-TPO antibodies were measured using MEIA by an automated analyzer AxSYM (ABBOTT, USA). The analytic sensitivity of the method was 1 kIU/l. Anti-TPO reference range was < 12 kIU/l. STATISTICAL ANALYSIS All data were presented as means and standard deviations if normally distributed or median and range if departing from the normal distribution. The categorical data were presented as proportions and 95% confi dence intervals. Normality was assessed by the Kolmogorov-Smirnoff test. Categorical data and proportions were analyzed by chi-square and 26 
THYROID FUNCTION
The studied characteristics in the subjects stratifi ed by gender are presented in Table 1 . The signifi cance levels refer to the comparison of the subjects with and without depression with the exception of the total, which compares males and females. The distribution of the studied subjects by TSH (low, normal or elevated) in the two genders is presented in Table 2 . The elevated TSH was more prevalent in the females (χ 2 = 14.93, p < 0.001).
DEPRESSION
The depressive score was higher in the females than in the males (47.6 ± 9.7 vs. 41.7 ± 8.6, p < 0.001); it was higher in the postmenopausal women than in the premenopausal ones (51.2 ± 9.9 vs. 44.3 ± 8.3, p < 0.001). The depressive score increased signifi cantly with the age in both genders (Spearman ρ females = 0.447, p < 0.001, ρ males = 0.402, p < 0.001) The SDS was lower in the males in all decades (all p < 0.05). (Fig. 1) .
The distribution of the subjects by depressive score, gender and TSH levels is presented in Table  3 . The mild and moderate depressive scores and the total depression were more prevalent in the females (all p < 0.001).
After stratifi cation of the subjects into groups by the TSH levels, the prevalence of depression remained higher in the females in all three groups. The difference was not signifi cant in the group with low TSH ( Table 2 ). The prevalence of depression was higher in the hypothyroid women than in the euthyroid women. The odds ratio for hypothyroidism-associated depression was 1.8, 95% CI 1.15-2.80, p < 0.011. No such association was found in the male subjects.
The subjects with high depressive scores were older, had a higher BMI and bigger waist circumference in both genders, and with higher TSH and anti-TPO antibodies in the females ( Table 1) .
The anti-TPO antibody levels were signifi cantly lower in the males than in the females in all SDSi groups except in the severe depression group, where the small subject number did not allow statistical analysis. The antibody levels rose with the depressive score in the females and declined in the males (Fig. 2) . The differences between the females and males were signifi cant for all categories (P < 0.001) except for severe depression. The differences between the females and males were signifi cant for all categories (p < 0.001) except for severe depression.
The infl uence of the various studied factors on depression was analysed using logistic regression ( Table 4 ). The factors that infl uenced signifi cantly the model were the gender and the age -the odds ratio for depression was 3.47 for the female gender and the risk rose by 6% with each additional year increase in the age. The anti-TPO antibody levels did not affect the model and was therefore excluded.
DISCUSSION
The Zung Self-rating Depression Scale has proved to be a tool with good repeatability and consistency with the results of other methods adopted in clinical practice. [11] [12] [13] Moreover, it is simple for administration in the settings of a large population-based screening which was the reason we used it in our study. To our best knowledge, most of the published studies on subjects with thyroid dysfunction have been carried out with other tools for depression assessment. The only two studies using Zung SDS that we were able to fi nd, reported results on subjects who underwent surgery for nodular goiter and hyperthyroidism. 10, 11 We could not fi nd any data regarding other thyroid disorders. We found several distinct characteristics in our cohort. Thirty-nine percent of the women and 18% of the men in the study had a positive depressive score, a prevalence rate which is much higher than that reported by other authors. 14 The prevalence rate of the subjects with moderate and severe depression was 11% for the females and 3% for the males which comes close to the rate obtained with other depression assessment tools. It may be assumed that the Zung SDS classifi es as mildly depressive the subjects with borderline characteristics, such that are not categorized as depressive if other tests are used. Previous studies in our country have yielded similar results. 15 These differences might be explained by the differences in the characteristics of the study contingent -social and economic status, educational level, place of living, employment status, marital status and age. Similar to the results of Kolchakova et al. 16 the depressive score in our cohort correlated positively with age. The regression model showed that the risk for depression rose by 6% for each additional year of age. The mean age of the subjects with high depressive scores was also higher for both genders, which is consistent with most published data. 17 No systematic explanation of this fi nding has been provided so far. Various physiological, social and household factors might interplay. There is however some controversy on the matter. In contrast to our and other authors' observations, Bebbington et al. reported a relative decline in the depression prevalence in postmenopausal women. 18 The difference in the depression occurrence between the two genders in their study was signifi cant only up to the age of 55. These fi ndings are supported in part by Wild B et al. 19 They studied a cohort in the age range of 53 to 80 and described a U-shaped curve of the prevalence of depressive disorders in this age interval.
The differences in the SDSi between the two genders remained after stratifi cation by thyroid function and the TSH level contributed minimally to the regression model. It might be assumed that there are differences between the males and the females in the way thyroid function affects mood and the SDSi. The prevalence of depression was higher in the hypothyroid subjects than it was in the euthyroid females, but no such difference was found in the males. Our results support the data reported by Fuller-Thomson E et al. 20 In a recent study they found that the odds ratio for deppression was 1.26 in hypothyroid females and 0.98 in hypothyroid males. Interestingly, Panicker V et al. found an inverse association between TSH and the prevalence of depression in euthyroid subjects, but not in hypothyroid ones on levothyroxine replacement therapy. 14 Such fi ndings might result from poor compliance to the levothyroxine therapy among the hypothyroid subjects with depression. That may contribute to the higher measured TSH. Another possible explanation is initially higher depression prevalence in the hypothyroid subjects, who seek medical advice and are diagnosed and receive replacement therapy. On the other hand, one cannot exclude endogenous causes for the differences -variations in the cerebral thyroid hormone transport or the deiodinase systems. [21] [22] [23] In a recent paper, Puia G et al. described a differentiating effect of T3 and T4 on the GABA-ergic neurons in the central nervous system. 24 In at least a part of the cases a role of thyroid autoimmunity may be suspected. Some studies point out an association between depression and antithyorid antibody levels 7 or between the treatment effect in depressive subjects and the antibody positivity. 25 We explored the association between anti-TPO antibody levels and depression in the studied group and found signifi cantly higher levels in the depressive females but not in the males. The antibody levels however did not infl uence signifi cantly the regression model even after stratifi cation by gender. Therefore, we did not confi rm any signifi cant effect of thyroid autoimmunity as measured by anti-TPO antibody levels, which conforms with the conclusions of Engum A et al. 8 The subjects with positive depressive score in both genders had higher BMI and bigger waist circumference, but these two factors also did not infl uence the regression model. For that reason we did not analyze them further. Moreover, the direction of a possible association is unclear.
The present study has several limitations. First, though convenient and reasonably informative, the Zung SDS is inferior to other tools used in clinical practice. Furthermore, depression is a multifactor disorder and the accurate analysis of any causal relationships requires controlling for a variety of factors such as family, social and employment conditions, heredity, and concomitant morbidity. Third, a single measurement of TSH cannot always assess correctly the thyroid function, especially when departing mildly from the reference range limits. Last but not least, due to the cross-sectional design of the study, the number of subjects with thyroid dysfunction is relatively small and as a result, the statistical power of the study decreases.
CONCLUSIONS
Despite these limitations, as a conclusion we observed a signifi cant association of Zung SDS with subjects' age and gender, presumably modifi ed by the thyroid function. The effect of thyroid autoimmunity, measured by the anti-TPO levels was not substantial. The results confi rm quite well our initial hypothesis, based on the reports of other researchers. Future studies on the interactions of thyroid autoimmunity with other factors may further elucidate the described associations.
